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Abstract
Canonical Wnt signaling is known to promote proliferation of olfactory stem cells. In order to
investigate the effects of a constitutive activation of Wnt signaling in Sox2-positive precursor
cells of the olfactory epithelium, we used transgenic mice that allowed an inducible deletion
of exon 3 of the Ctnnb1 gene, which is responsible for the phosphorylation and degradation
of Ctnnb1 protein. After induction of aberrant Wnt activation by Ctnnb1 deletion at embry-
onic day 14, such mice developed tumor-like lesions in upper parts of the nasal cavity. We
still observed areas of epithelial hyperplasia within the olfactory epithelium following early
postnatal Wnt activation, but the olfactory epithelial architecture remained unaffected in
most parts when Wnt was activated at postnatal day 21 or later. In summary, our results
suggest an age-dependent tumorigenic potential of aberrant Wnt signaling in the olfactory
epithelium of mice.
Introduction
The mammalian olfactory epithelium (OE) is a sensory neuroepithelium, which is unique
for its ability of sustaining robust peripheral neurogenesis throughout the lifetime of mice
and man [1–4]. The complex regulatory pathways underlying this physiologic capacity
have been a matter of intensive biomedical research, given the hope, that major insights
here might sustainably transform the field of regenerative medicine in the future. Only
recently, the crucial role of the canonical Wnt signaling pathway in the regulation of OE
stem cells and progenitors during development and regeneration has been pointed out [5,
6]. Wang et al. showed, that Wnt signaling promotes self-renewal of Sox2-positive stem
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cells and proximate progenitors of the OE in vitro [5]. Moreover, Wnt signaling was found
to promote neurogenesis at the expense of non-neuronal differentiation within the OE.
Following OE injury in adult mice, strong Wnt activation seems to be necessary for OE
regeneration in vivo. In this context, Chen et al. confirmed that Wnt activation may have a
pivotal role in OE progenitor cell proliferation and neurogenesis in vivo, and they further
suggested that Wnt signaling delays the terminal differentiation of neuronal progenitors
into mature olfactory sensory neurons, therefore promoting the expansion of OE immature
neuronal progenitors [6].
Beyond the physiological role of Wnt signaling for the regulation of cellular growth and dif-
ferentiation throughout the body, pathological activation of the canonical Wnt signaling path-
way has been identified to play a crucial role in a wide range of human neoplastic diseases [7–
13]. Of note, the Wnt pathway hereby often takes up important physiologic functions and has
devastating tumor-causing potential in cases of dysregulation within the same tissue. This is
exemplarily true for intestinal tissue homeostasis [14, 15] and colon cancer formation [16–18].
In the central nervous system, Wnt signaling has for instance crucial roles in hindbrain devel-
opment [19–22] and may induce WNT medulloblastoma formation [12]. This relation is even
generalizable to the well-established link between the essential role of certain signaling path-
ways for brain development and their contribution to the pathogenesis of various human pedi-
atric brain tumors [23].
Here, we sought to answer the question, whether the above outlined parallelism is valid in
an OE related context, which would imply a tumorigenic potential of aberrant Wnt signaling
within the OE. Thus, we constructed an inducible Sox2-creERT2::Ctnnb1(ex3)Fl/+mouse model
in order to effectively delete exon 3 of Ctnnb1 in Sox2-positive cells of the mouse OE. The




Sox2-creERT2 [24] and B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J [25] mice were obtained
from the Jackson Laboratory. Ctnnb1(ex3)Fl/FL [26] mice were a kind gift from Dr. M.
Taketo (University of Tokyo, Japan). Genotyping was performed by PCR analysis using
genomic DNA from ear biopsies. Primers for Cre and Ctnnb1(ex3) have been previously
published [26, 27], and primers to detect the tdTomato allele have been designed as recom-
mended by the Jackson Laboratory (www.jax.org). In vivo induction of the tdTomato or the
defective Ctnnb1(ex3) allele in Sox2-positive cells was achieved by intraperitoneal tamoxi-
fen (Sigma-Aldrich) injection. Pregnant females were injected once with 1 mg of tamoxifen
(50 mg/kg body weight in corn oil (Sigma-Aldrich) at E14.5. The day of vaginal plug detec-
tion was considered E0.5. Postnatal mice were induced at days P7, P14 or P21 via single
tamoxifen injection, likewise. Injected mice were monitored daily for signs of tumor for-
mation or general failure to thrive. Together with littermates not bearing the Cre allele,
mutant animals destined for further histological workup were sacrificed shortly after the
onset of symptoms by cervical dislocation. All mouse procedures were performed accord-
ing to protocols approved by the government of Upper Bavaria (#2532-10-14). All efforts
were made to ameliorate suffering of mice. Mice were sacrificed by cervical dislocation as
soon as any kind of suffering, deterioration of the general health condition or neurological
symptoms were visible. This given, analgesics or anesthetics were not applied in order to
reduce suffering. Mice were monitored at least once a day. There were no unexpected
deaths within this study.
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Tissue collection, fixation and H&E staining
Sacrificed animals destined for histological evaluation were immediately dissected for tissue
collection. The skull bases were formalin-fixed, decalcified in 10% EDTA (pH7.4) and embed-
ded in paraffin according to standard lab protocols. For each of those animals, brain, heart,
lungs, gastrointestinal organs and kidneys were collected and separately fixed and embedded
according to standard lab protocols. The preserved skull base specimens were cut in frontal
orientation until a level with intersection of ethmoturbinates 1–5 was reached. Sections from
this level were collected and H&E stains were acquired according to standard lab protocols.
For all other organs, representative H&E stains in suitable orientation were evaluated for histo-
morphological alterations in mutant organs compared to controls. If alterations were detect-
able, further immunohistochemical staining was performed as described below.
Immunohistochemistry
Sections of paraffin-embedded tissue were deparaffinized and rehydrated before heat-induced
antigen retrieval was conducted at 100˚C for 20 min in 10 mM sodium citrate buffer for all
antibodies. Immunohistochemical staining was done using the primary antibodies in concen-
trations as follows: RFP: 1:200, Antibodies Online, Cat N˚ AA234; Sox2: 1:200, Abcam, Cat N˚
AB79351; Ki67: 1:200, Abcam, Cat N˚ AB16667, Beta-Catenin: 1:1000, BD Pharmigen, Cat N˚
610153; Mash1: 1:25, BD Bioscience, Cat N˚ 556604; Chromogranin A: 1:300, Abcam, Cat N˚
AB15160; CD56: undiluted, Ventana Medical Systems, Roche, Cat N˚ 7602625; S100: 1:2000,
DAKO, Cat N˚ Z0311; SMA: 1:1000, DAKO, Cat N˚ M0851. Mash1 antibody was applied in
blocking puffer over night at room temperature [28]. All other antibodies were applied over
night at 4˚C. The HRP/DAB Staining System (DAKO) was used according to the manufactur-
er’s specifications. Hemalaun was used for nuclear counterstaining. All histological photomi-
crographs were taken digitally using an Olympus BX50 microscope in combination with the
Color View Soft imaging system. For immunofluorescent staining, sections were washed twice
with PBS/0.1% Triton X-100 and then incubated in blocking buffer (I-Block protein- based
blocking reagent; Applied Biosystems) for 30 minutes. Primary antibodies (RFP: 1:200, Anti-
bodies Online, Cat N˚ AA234; Sox2: 1:200, Abcam, Cat N˚ AB79351; Tuj1: 1:100, BABCO, Cat
N˚ MMS435P) were diluted in blocking buffer and applied over night at 4˚C. Next, sections
were washed twice with PBS/0.1% Triton X-100 and incubated for another 60 minutes with a
1:500 dilution of fluorescence-labeled secondary antibodies (goat anti-rabbit Alexa546; goat
anti-mouse Alexa488, Invitrogen) in blocking buffer. Sections were washed twice with PBS/
0.1% Triton X-100, counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and mounted
in Fluorescent Mounting Medium (DAKO). Images of tissue sections were collected on a Zeiss
LSM 780 laser scanning microscope in combination with the ZEN 2012 imaging software.
Whole-mount images of stomachs were collected on a Leica DFC3000 G microscope camera
in combination with the Leica Application Suite Software.
Statistical analysis
Data of survival, body weight and body seize of mice were analyzed using the Prism5 software
(GraphPad). Survival of mice was analyzed using Kaplan–Meier survival curves, and the log
rank test was used to examine the significance of results. P-values <0.05 were considered sig-
nificant. For the analysis of body size and body weight of mice, the unpaired t-test was applied
to compare the means of two groups with assumed Gaussian distribution and equal variances.
All respective histograms illustrate the standard error of the mean (SEM; error bars).
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Results
The main cell types of the mature OE originate mainly from
Sox2-positive progenitor cells
The mature OE structure is composed of neuronal and non-neuronal OE cells. As we did not
know, which OE cell lineage might be susceptible for aberrant Wnt signaling, we aimed for a
Cre-driver strain that broadly targets the OE. It is known that OE stem cell populations as well
as OE sustentacular cells express the transcription factor Sox2 [29]. To investigate the suitabil-
ity of a Sox2-driver for our purpose, we first examined the Sox2-expression within the OE of
wild typemouse embryos. We regarded the mouse embryonic day E14.5 as an ideal time for
this investigation and for the later Cre-driver-based fate-mapping studies within the OE, first,
because the basic composition of the mature OE is known to be established between E13.5 and
E15.5 [30] and, second, we expected the maximum impact of inserted mutations within the
OE to be realized by early time point mutational induction. As expected, E14.5 mouse OE tis-
sue shows remarkable Sox2 expression (Fig 1A) in mitotically active apical and basal progeni-
tor cells, which include a putative stem cell pool [31].
Next, we wanted to examine how the progeny of these Sox2-positive cells contribute to the
cellular composition of the olfactory epithelium. Therefore, we bred Sox2-creERT2 mice with a
red fluorescent protein (RFP) variant (tdTomato) reporter strain (Fig 1B), induced this fate-
mapping system via a single intraperitoneal tamoxifen injection of pregnant females at E14.5,
and sacrificed the mice at the day of birth (P0). While immunohistochemical staining for RFP
on OE tissue of Cre-negative animals was negative (data not shown), “effective” mutant mice
revealed a homogenous staining of the whole OE structure, indicating that close to every cell
within the OE at P0 stemmed from a Sox2-positive precursor cell (Fig 1D). These fate-mapped
OE cells comprised all major cell types of the postnatal OE as demonstrated by double-immu-
nofluorescent staining: Sox2/RFP-positive stem cells at the OE base (Fig 1C–1E, arrows),
Sox2/RFP-positive sustentacular cells at the apical OE site (Fig 1C–1E, nuclei of sustentacular
cells below dashed line) and Tuj-1/RFP-positive cells that belong to the neuronal OE lineage
(Fig 1F–1H). Even in the mature OE at postnatal day P28, a homogenous and specific RFP
staining throughout the OE was observed (Fig 1J; Fig 1I shows control), indicating that the
stem cell pool, necessary for postnatal OE expansion and regeneration does not arise indepen-
dently from Sox2-precursors at E14.5, but is a progeny of those. Interestingly, similar results
are observed, if Tamoxifen is applied at P21, although the RFP staining at P42 is a little more
heterogeneous in this situation (S1 Fig).
We concluded that no large cell population different from Sox2-positive progenitor cells,
targetable as early as E14.5, contributes to the cellular composition of the mature OE. There-
fore, the Sox2-creERT2mouse appears to be a suitable driver strain for performing gene func-
tion studies within the OE, irrespective of cell type of interest. Likewise, E14.5 seemed to be an
appropriate time point of a genetic manipulation in order to elicit a well-marked phenotype at
postnatal days. As the late-embryonically established pattern of Sox2-expression within the OE
remains preserved at postnatal stages of development [29], the postnatal OE structure even
continues to be targetable for our model approach. Thus, we also considered model induction
at postnatal days of development.
Constitutive activation of the canonical Wnt signaling pathway at E14.5
leads to the formation of tumor-like lesions within the OE of mice
To model a constitutive activation of the canonical Wnt signaling pathway within the OE, as
being found in a plethora of human neoplastic diseases, we next bred Sox2-creERT2mice to
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Fig 1. The Sox2-CreERT2 mouse is a suitable driver strain for studying gene function in the mouse olfactory
epithelium (OE). At embryonic day 14.5 of mouse development (E14.5) the transcription factor Sox2 is already expressed
in basal and apical progenitor cells of the olfactory epithelium (A). The mouse breeding scheme used in this study is displayed
in panel B. Model induction via single tamoxifen application at E14.5 targets the whole progeny of the OE structure present
at the day of birth (P0) as demonstrated in a Sox2-creERT2::tdTomato reporter strain (D). These targeted cells comprise
Sox2-positive stem cells at the basal site of the OE (arrows, C-E), non-neuronal apical Sox2-positive sustentacular cells
(nuclei of sustentacular cells delineated by dashed line, C-E) as well as Tuj-1-positive neuronal cells of the OE (a Tuj1/RFP-
double-positive cell is depicted in high power insets, F-H). Single embryonic tamoxifen injection of Sox2-creERT2::tdTomato
Wnt-Driven Lesions in the Olfactory Epithelium
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Ctnnb1(ex3)Fl/Flmice and induced the model via single intraperitoneal tamoxifen injection of
pregnant females at E14.5. The offspring expressed an exon 3 depleted version of the Beta-
Catenin protein, preventing its degradation [26] and resulting in a constitutive activation of
the Wnt signaling pathway in Sox2-expressing cells at E14.5 and their progeny throughout the
body. These Sox2-creERT2::Ctnnb1(ex3)Fl/+mice developed a marked failure to thrive until the
age of postnatal day P21 with significant deficits in body size and body weight compared to
controls (Fig 2A–2D) and presented with general weakness and ataxia. Finally, all of these
mice had to be sacrificed 3 to 4 weeks after birth (Fig 2E). An orienting histopathological
review of the major organ systems of embryonically tamoxifen-injected mice, covering brain,
heart, lungs, kidneys and the gastrointestinal tract revealed unusual small stomachs in
mutants, bearing hyperplastic, lumen-narrowing lesions in glandular and non-glandular parts
of the organ (S2 Fig; organ systems of postnatally induced mice not examined). These lesions
might contribute to malnutrition and malabsorption, which would offer a plausible explana-
tion for the phenotype of mutant mice.
The OE architecture of these mutant mice was demolished and had become replaced by
tumorous tissue, slightly pronounced in the upper part of the nasal cavity (Fig 3H and 3I; Fig
3A and 3B shows control). These mouse OE lesions displayed signs of infiltration with disrup-
tion of bone laminae (Fig 3J) and rosette-like differentiation features (Fig 3K) compared to the
normal mouse OE (Fig 3C). However, the amount of Ki-67-positive cells in the OE mouse
tumor-like lesions appeared to be not visually altered compared to native OE tissue (Fig 3L vs.
animals is sufficient to cover the whole mature OE in adult mice as shown for P28 (J; specific RFP detection compared to
control in I). Scale bars equate to 500 μm in I-J, 25 μm in A and 10 μm in C-H.
doi:10.1371/journal.pone.0166690.g001
Fig 2. Embryonically induced mutant mice present with a failure to thrive and die prematurely when compared to
controls. At E14.5 tamoxifen-induced Sox2-creERT2::Ctnnb1(ex3)Fl/+ mice develop a marked failure to thrive compared to
controls (B vs. A) and show significant deficits in body size (C) and body weight (D) at their time of death. Mutant mice had to be
sacrificed prematurely between postnatal days 21–28 (E).
doi:10.1371/journal.pone.0166690.g002
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Fig 3. Embryonically activated aberrant Wnt signaling in Sox2-creERT2::Ctnnb1(ex3)Fl/+ mice leads to
the formation of tumor-like lesions within the olfactory epithelium. Tamoxifen application in
Sox2-creERT2::Ctnnb1(ex3)Fl/+ mice at E14.5 causes aberrant activation of the canonical Wnt signaling
pathway in Sox2-positive cells of the mouse OE and leads to the formation of tumor-like lesions within this
structure. As shown for P21 mice by H&E staining, the structure of the native OE in mutant mice compared to
controls is fully disrupted. Alterations are more pronounced in the upper nasal cavity (A, OE of control mice; B,
higher magnification of framed area in A; H, OE tumor-like lesions of mutant mice; I, higher magnification of
framed area in C). OE tumor-like lesions of mutant mice display signs of infiltration with disruption of bone
laminae (C, control OE; J, red dashed line indicates broken bone barrier in mutant OE lesions) as a feature of
Wnt-Driven Lesions in the Olfactory Epithelium
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3D). Immunohistochemical staining allowed the detection of Sox2, Mash1, a marker of early
neuronal lineage restriction in the OE, and nuclear accumulation of Beta-Catenin, a correlate
of activated canonical Wnt signaling, in the native P21 mouse OE (Fig 3E–3G). Mouse OE
tumor-like lesions expressed these markers as well, but marker expression here seemed to
delineate nests of stained cells surrounded by an unstained stromal cell compartment (Fig
3M–3O). Additional stains revealed expression of CD56, Chromogranin A, S100, but not
Smooth muscle actin (SMA, Fig 4). In summary, the embryonical induction of aberrant Wnt
signaling in the OE of mice lead to the formation of tumor-like lesions with a hinted nest-
stroma cytoarchitecture.
Postnatally induced aberrant Wnt signaling within the OE leads to an
age-dependent formation of OE hyperplasia
In a next step we wanted to test, whether such OE tumor-like lesions would be reproducible by
aberrant activation of the canonical Wnt signaling pathway in the OE of mice at postnatal
stages of development. Therefore, we injected Sox2-creERT2::Ctnnb1(ex3)Fl/+mice and Sox2--
creERT2mice as controls with single tamoxifen dosages at postnatal days P7, 14 or 21. Analo-
gous to the embryonically injected mutant mice, postnatally induced mice developed a
marked failure to thrive shortly after tamoxifen treatment and had to be sacrificed within 2
weeks after tamoxifen injection (data not shown). Compared with embryonically induced
mutants, the OE cytoarchitecture of postnatally induced mice appeared to be grossly intact.
However, P7 and P14 induced mutant mice presented with areas of epithelial hyperplasia aris-
ing from the otherwise normal OE structure (OE hyperplasia in a representative P7 induced
mutant in Fig 5C and 5D compared to control in Fig 5A and 5B; OE hyperplasia in a represen-
tative P14 induced mutant in Fig 5G and 5H compared to control in Fig 5E and 5F). Immuno-
histochemical staining of such OE hyperplasia for Ki67, Sox2, Beta-Catenin and Mash1 did
neither lead to the assumption of a remarkably impaired cell differentiation nor a visibly
increased proliferation rate in such lesions compared to controls (Fig 5I–5P). The basal-apical
polarity of the native OE was largely preserved.
When mutant mice were induced not until P21, the OE of such mutant mice remained
indistinguishable from the native OE of controls (Fig 5Q–5T) and hyperplasia was not
observed.
Altogether, this age-dependent capacity of aberrant Wnt activation, which induces hyper-
plastic growth in the postnatal OE as well as the more tumor-like phenotype of OE lesions
seen in embryonically induced mutants, may suggest an age-dependent tumorigenic potential
of pathological aberrant Wnt signaling within the OE of mice.
Discussion
We report here a mouse model system, in which the artificially induced constitutive activation
of the canonical Wnt signaling pathway at E14.5 drives the formation of tumor-like OE lesions
from Sox2-positive precursors of the OE structure. Furthermore, Wnt activation at early
malignant growth. Rosette-like structures are present in OE lesions of mutants (C, control OE; K, rosette in
mutant OE lesion indicated by arrow). The amount of Ki67-positive cells in mouse OE tumor lesions remains
comparable to the native OE (D, control OE; L, mutant OE lesion). Staining for Sox2, ß-Catenin and Mash1
delineate tumor cell nests from a surrounding stromal cell compartment (E, F, G, control stains; M, N, O,
stains in mutant OE lesions). Scale bars equate to 500 μm in A and H, equate to 100 μm in B and I, equate to
25 μm in C-G and J-O and equate to 5 μm in insets.
doi:10.1371/journal.pone.0166690.g003
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postnatal stages of mouse development leads to an OE hyperplasia without obvious malignant
features.
As such, the tumorigenic potential of pathological activated Wnt signaling within the
murine OE seems to fade out with age and completely disappears at the age of about 3 weeks.
These results are not unexpected, as massive OE cell proliferation is a physiological process in
embryonic and early postnatal OE development [32], and one would expect a generally more
permissive microenvironment for proliferation during these stages. Around 30 days after
mouse birth, this mode of cell expansion finally slows down into a state of OE maintenance
[32] with consecutively low cell-turnover, leading to the assumption of a then more prolifera-
tion-suppressing environment.
Interestingly, even the tumorous lesions observed after Wnt activation in the developing
murine OE et E14.5 do not demonstrate a grossly enhanced proliferation rate compared to
controls. However, this finding does not necessarily vote against the neoplastic character of the
lesion. Olfactory neuroblastoma, for instance, that are believed to arise from the olfactory epi-
thelium, do neither proliferate extensively [33]. Furthermore, canonical Wnt signaling is
known to have the capability to block apoptosis, as demonstrated in mesenchymal cells [34,
35]. It therefore appears possible that aberrant Wnt signaling in the olfactory epithelium dis-
turb the physiological cell turnover by a blockade of apoptosis rather than significantly to
enhance the rate of proliferation.
Obvious similarities concerning neoplastic lesions of human head and neck pathology to
our postnatally induced mouse OE hyperplasia, which reminded us of the classical adenoma-
carcinoma sequence in colorectal carcinogenesis [36, 37], are missing. Sinonasal polyposis is a
common disease in human beings, but is considered to produce benign hyperplastic lesions
associated with chronic inflammation, rather than forming precursor lesions of future malig-
nant transformation, driven by somatic or inherited mutations [38, 39]. Also, inflammatory
nasal polyps are not likely to arise from the olfactory mucosa [40]. However, an upregulation
of Wnt pathway genes in nasal polyposis has been reported [41].
A malignant human tumor that is thought to arise from the human OE [42] is the olfactory
neuroblastoma (esthesioneuroblastoma), and we noticed some similarities of our embryoni-
cally induced OE tumor-like lesions and human olfactory neuroblastoma (hONB) on the level
of histopathology, including positive staining for markers of neuroendocrine differentiation,
such as CD56 and Chromogranin A (Fig 4A–4D). Similarly, S100 expression is used to differ-
entiate hONB from neuroendocrine carcinoma [43, 44] and is detectable in our mouse OE
lesions as well (Fig 4E and 4F). hONB is a rare sinonasal malignancy of neuroectodermal dif-
ferentiation, but due to its rarity, very little is known about the molecular basis of ONB forma-
tion. However, nuclear accumulation of Beta-Catenin as a correlate of constitutive activation
of the canonical Wnt signaling pathway, which is detectable in mouse OE tumor-like lesions
and native mouse OE tissue, was not detectable in any of 27 analyzed bona fide hONB (unpub-
lished observations).
In recent years, sinonasal haemangiopericytoma (sHPC) have been proposed as an inde-
pendent tumor entity that is distinct from solitary fibrous tumors of the sinonasal tract and
Fig 4. Additional immunohistochemical staining of tumor-like lesions in embryonically induced
mutant mice suggest similarity to human olfactory neuroblastoma (hONB), but distinctness from
human sinonasal haemangiopericytoma (sHPC). The expression of markers of neuroendocrine
differentiation as CD56 and Chromogranin A and positivity for S100 are crucial requirements for the proper
diagnosis of hONB and can be detected in OE mouse tumor-like lesions (B, D, F), but are found to be absent in
the native mouse OE (A, C, E). SMA is known to be widely diffuse positive in sinonasal haemangiopericytoma
but does not homogenously stain cells in our mouse tumor-like lesions (H) or native mouse OE (G). Scale bars
equate to 25 μm.
doi:10.1371/journal.pone.0166690.g004
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meningeal HPC [45]. Most notably, sHPC have been found to harbor frequent CTNNB1muta-
tions [46, 47], ranking this tumor entity as a strong candidate for offering an equivalent to our
mouse OE tumor-like lesions in human pathology. However, the histological phenotype of
Fig 5. Early postnatally activated aberrant Wnt signaling in Sox2-creERT2::Ctnnb1(ex3)Fl/+ mice leads to the formation of epithelial
hyperplasia within the OE. Tamoxifen application in Sox2-creERT2::Ctnnb1(ex3)Fl/+ mice at postnatal day 7 (P7) or 14 (P14) leads to the formation of
OE hyperplasia (A, E, OE of control mice; B, F, higher magnification of framed areas in A, E showing normal OE; C, hyperplasia in P7-induced mutant
mice; D, higher magnification of framed area in C; G, multiple areas of hyperplasia in P14-induced mutant mice captured on different slice levels; H,
higher magnification of framed area in G). IHC staining patterns for Ki67, Sox2, ß-Catenin and Mash1 of exemplary areas of hyperplasia in P14-induced
mutant mice are comparable to control OE, indicating a grossly normal cell differentiation and preserved OE polarity in such areas (I, J, M, N, IHC stains
of control mice OE; K, L, O, P, respective IHC stains of hyperplasia; insets display high power magnifications of framed areas in I-P and exemplarily
highlight positive cells for the respective marker). At postnatal day 21 (P21) tamoxifen-induced mutant mice do not develop those alterations anymore
(Q-T). Scale bars equate to 500 μm in A, C, E, G, Q and S, equate to 100 μm in B, D, F, H, R and T, equate to 50 μm in I-P, and equate to 10 μm in insets.
doi:10.1371/journal.pone.0166690.g005
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sHPC has been described to be quite different from what we encounter in our OE model
lesions. In particular, one would expect a vascular endothelial differentiation in these probably
pericyte-derived tumors instead of the rather neuroendocrine differentiation profile of our
mouse OE lesions. Furthermore, strong and diffuse cytoplasmatic expression of smooth-mus-
cle actin (SMA) is a consistent feature of human sHPC [45, 48], but is hardly detectable in our
mutant mouse OE lesions (Fig 4G and 4H).
Owed to the limited lifespan of the introduced mouse model we described relatively small
OE tumor-like lesions in this study, even after embryonic induction of Wnt-pathway activity.
Nevertheless, the described lesions clearly indicate that a tight control on Wnt signaling is
required in the developing olfactory epithelium. More work is required to understand, to
which extent the variety of human sinonasal neoplasms may develop with the contribution of
activated Wnt signaling and whether Sox2-positive precursors in the olfactory epithelium
could indeed serve as a cellular origin for such tumors.
Supporting Information
S1 Fig. Immunostaining using antibodies against RFP on frontal sections from 42-day-old
Sox2-creERT2::tdTomato mice with tamoxifen application at P21. Higher magnifications at
the bottom display medial (left) and lateral (right) regions.
(TIF)
S2 Fig. Embryonically induced mutant mice display small stomachs with hyperplastic
lesions in glandular and non-glandular parts of the organ at the time of death. At E14.5
tamoxifen-induced Sox2-creERT2::Ctnnb1(ex3)Fl/+mice display small stomachs at the time of
death compared to controls (whole organ in C vs. A; sliced organ in D vs. B). The stomachs of
mutant mice exhibit lumen-narrowing hyperplastic lesions in forestomach (G vs. E) and glan-
dular stomach (H vs. F) parts. The epithelial cells of forestomach lesions show an endophytic
growth pattern (K vs. I) with visually enhanced proliferation in Ki67 staining (O vs. M) in
comparison to the native forestomach epithelium. The glandular lesions present altered
cytoarchitecture and cell morphology compared to the native glandular stomach (L vs. J),
whereas ß-Catenin staining intensity seems to be enhanced in these lesions (T vs. R; higher
magnification of framed areas in insets). Ki67 staining in glandular lesions and native glands
(P vs. N) and ß-Catenin staining in forestomach lesions and native forestomach (S vs. Q) is
similar. Scale bars equate to 2 mm in A-D, equate to 500 μm in E-H, equate to 50 μm in I-P,
equate to 20 μm in Q-T and equate to 10 μm in insets.
(TIF)
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